Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Related Posts
Bitmine Keeps Buying Ethereum Despite Market Drop: 21,054 ETH Arrive In New Wallet
Ethereum has come under heavy selling pressure over the past few days as the broader crypto market entered a deep corrective phase. Yet, despite the volatility and widespread fear, ETH has managed to hold firmly above the key $3,000 level — a zone many analysts consider essential for maintaining the broader bullish structure. Now, as […]
Ripple Pushes Global Compliance Expansion Ahead Of US Clarity Act Debate
Ripple Pushes Global Compliance Expansion Ahead Of US Clarity Act Debate: what the validated data shows, why it matters for crypto markets, and the caveat.
Market Expert Says Investors Will No Longer Be Able To Buy XRP Directly – Here’s Why
Market expert and software engineer Vincent Van Code has issued a direct warning that investors may soon lose the ability to buy native XRP through direct traditional retail channels. He outlined an upcoming shift in how the cryptocurrency will be accessed, pointing to a future where the altcoin is obtained only through institutional products. Why […]



